Small bowel adenocarcinoma

Current Treatment Options in Oncology

Volumn 9, Issue 4-6, 2008, Pages 388-399

  Zouhairi, Majed El ^a   Venner, Allison ^a   Charabaty, Aline ^b   Pishvaian, Michael J ^c  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GEORGETOWN UNIVERSITY   (United States)

^c GEORGETOWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPECITABINE; CISPLATIN; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; MITOMYCIN C; OXALIPLATIN; ANTINEOPLASTIC ANTIMETABOLITE;

ADENOCARCINOMA; ADVANCED CANCER; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER RISK; CANCER STAGING; CAPSULE ENDOSCOPY; CARCINOGENESIS; CLINICAL TRIAL; CONTINUOUS INFUSION; DIAGNOSTIC IMAGING; DOUBLE BALLOON ENTEROSCOPY; ENDOSCOPIC THERAPY; ENVIRONMENTAL FACTOR; GENE MUTATION; GENETIC RISK; HUMAN; METASTASIS; NONHUMAN; PROGNOSIS; REVIEW; SMALL INTESTINE CANCER; SMALL INTESTINE CARCINOMA; TREATMENT RESPONSE; ANIMAL; DISEASE MODEL; FEMALE; GENETICS; INTESTINE TUMOR; MALE; MIDDLE AGED; MORTALITY; MOUSE; ONSET AGE; PATHOLOGY; RISK FACTOR; SMALL INTESTINE; UNITED STATES;

ADENOCARCINOMA; AGE OF ONSET; ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; DISEASE MODELS, ANIMAL; FEMALE; FLUOROURACIL; HUMANS; INTESTINAL NEOPLASMS; INTESTINE, SMALL; MALE; MICE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RISK FACTORS; UNITED STATES;

EID: 70249118587     PISSN: 15272729     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11864-009-0098-0     Document Type: Review

References (40)

1. Neugut AI, Jacobson JS, Suh S, Mukherjee R, Arber N: The epidemiology of cancer of the small bowel. Cancer Epidemiol Biomarkers Prev 7, 243-251 (1998)
2. Jemal A, Ward E, Thun MJ: Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women. Breast Cancer Res 9, R28 (2007). doi: 10.1186/bcr1672
3. Delaunoit T, Neczyporenko F, Limburg PJ, Erlichman C: Pathogenesis and risk factors of small bowel adenocarcinoma: A colorectal cancer sibling? Am J Gastroenterol 100, 703-710 (2005). doi: 10.1111/ j.1572-0241.2005.40605.x
4. Howe JR, Karnell L, Menck HR, Scott-Conner C: Adenocarcinoma of the Small Bowel Review of the National Cancer Data Base, 1985-1995. Cancer 86, 2693-2706 (1999). doi: 10.1002/ (SICI)1097-0142(19991215)86:12<2693::AID-CNCR14>3.0.CO;2-U
5. Moser AR, Pitot HC, Dove WF: A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science 247, 322-324 (1990). doi: 10.1126/science.2296722
6. Wu AH, Yu MC, Mack TM: Smoking, alcohol use, dietary factors and risk of small intestinal adenocarcinoma. Int J Cancer 70, 512-517 (1997). doi: 10.1002/(SICI)1097-0215(19970304)70:5<512::AID-IJC4>3.0.CO;2-0
7. Arai M, Shimizu S, Imai Y et al.: Mutations of the Ki-ras, p53 and APC genes in adenocarcinomas of the human small intestine. Int J Cancer 70, 390-395 (1997). doi: 10.1002/ (SICI)1097-0215(19970207)70:4<390::AID-IJC3>3.0.CO;2-R
8. Younes N, Fulton N, Tanaka R et al.: The presence of K-12 ras mutations in duodenal adenocarcinomas and the absence of ras mutations in other small bowel Esophageal/Gastric Small and Large Bowel/Anal Cancer adenocarcinomas and carcinoid tumors. Cancer 79, 1804-1808 (1997). doi: 10.1002/(SICI)1097-0142(19970501)79:9<1804::AID-CNCR24>3.0.CO;2-0
9. Howdle PD, Jalal PK, Holmes GK, Houlston RS: Primary small-bowel malignancy in the UK and its association with coeliac disease. QJM 96, 345-353 (2003). doi: 10.1093/qjmed/hcg058
10. Hutchins RR, Bani Hani A, Kojodjojo P, Ho R et al.: Adenocarcinoma of the small bowel. ANZ J Surg 71, 428-437 (2001). doi: 10.1046/ j.1440-1622.2001.02149.x
11. Verma D, Stroehlein JR: AdenoAarcinoma of the small bowel: a 60-yr perspective derived from M.D. Anderson Cancer Center Tumor Registry. Am J Gastroenterol 101, 1647-1654 (2006). doi: 10.1111/ j.1572-0241.2006.00625.x
12. Bender GN, Aaglinte DD, Kloppel VR, Timmons JH: CT enteroclysis: a superfluous diagnostic procedure or valuable when investigating small-bowel disease? AJR Am J Roentgenol 172, 373-378 (1999)
13. Horton KM, Fishman EK: Multidetector-row computed tomography and 3-dimensional computed tomography imaging of small bowel neoplasms: current concept in diagnosis. J Comput Assist Tomogr 28, 106-116 (2004). doi: 10.1097/00004728-200401000-00019
14. Pilleul F, Penigaud M, Milot L et al.: Possible small-bowel neoplasms: contrast-enhanced and water-enhanced multidetector CT enteroclysis. Radiology 241, 796-801 (2006). doi: 10.1148/radiol.2413051429
15. Gill SS, Heuman DM, Mihas AA: Small intestinal neoplasms. J Clin Gastroenterol 33, 267-282 (2001). doi: 10.1097/00004836-200110000-00004
16. Ell C, Remke S, May A et al.: The first prospective controlled trial comparing wireless capsule endoscopy with push enteroscopy in chronic gastrointestinal bleeding. Endoscopy 34, 685-689 (2002). doi: 10.1055/ s-2002-33446
17. Maglinte DD, Sandrasegaran K, Chiorean M et al.: Radiologic investigations complement and add diagnostic information to capsule endoscopy of small-bowel diseases. AJR Am J Roentgenol 189, 306-312 (2007). doi: 10.2214/AJR.07.2253
18. Van Dam J, Brugge WR: Endoscopy of the upper gastrointestinal tract. N Engl J Med 341, 1738-1748 (1999). doi: 10.1056/NEJM199912023412306
19. Pasha SF, Leighton JA, Das A et al.: Double-balloon enteroscopy and capsule endoscopy have comparable diagnostic yield in small-bowel disease: A metaanalysis. Clin Gastroenterol Hepatol 6, 671-676 (2008). doi: 10.1016/j.cgh.2008.01.005
20. Dabaja BS, Suki D, Pro B et al.: Adenocarcinoma of the small bowel: presentation, prognostic factors, and outcome of 217 patients. Cancer 101, 518-526 (2004). doi: 10.1002/cncr.20404
21. Wu TJ, Yeh CN, Chao TC et al.: Prognostic factors of primary small bowel adenocarcinoma: Univariate and multivariate analysis. World J Surg 30, 391-398 (2006) (discussion 399, 2006)
22. Bakaeen FG, Murr MM, Sarr MG et al.: What prognostic factors are important in duodenal adenocarcinoma? Arch Surg 135, 635-641 (2000) (discussion 641-632)
23. Friedrich-Rust M, Ell C: Early-staAe small-bowel adenocarcinoma: a review of local endoscopic therapy. Endoscopy 37, 755-759 (2005)
24. Talamonti MS, Goetz LH, Rao S, Joehl RJ: Primary cancers of the small bowel: Analysis of prognostic factors and results of surgical management. Arch Surg 137, 564-570 (2002) (discussion 570-561)
25. Oka S, Tanaka S, Nagata S et al.: Clinicopathologic features and endoscopic resection of early primary nonampullary duodenal carcinoma. J Clin Gastroenterol 37, 381-386 (2003)
26. Hirasawa R, Iishi H, Tatsuta M, Ishiguro S: Clinicopathologic features and endoscopic resection of duodenal adenocarcinomas and adenomas with the submucosal saline injection technique. Gastrointest Endosc 46, 507-513 (1997)
27. Fishman PN, Pond GR, Moore MJ et al.: Natural history and chemotherapy effectiveness for advanced adenocarcinoma of the small bowel: A retrospective review of 113 cases. Am J Clin Oncol 29, 225-231 (2006)
28. Halfdanarson TR, Quevedo F, McWilliams RR: Small bowel adenocarcinoma: A review of 491 cases. J Clin Oncol 24, 4127 (2006) In ASCO Annual Meeting Proceedings 2006
29. Coia L, Hoffman J, Scher R et al.: Preoperative chemoradiation for adenocarcinoma of the pancreas and duodenum. Int J Radiat Oncol Biol Phys 30, 161-167 (1994)
30. Andre T, Boni C, Mounedji-Boudiaf L et al.: Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 350, 2343-2351 (2004)
31. Ouriel K, Adams JT: Adenocarcinoma of the small intestine. Am J Surg 147, 66-71 (1984)
32. Czaykowski P, Dui H: Chemotherapy for small bowel adenocarcinoma (SBA): experience over a 10-year period at the BC Cancer Agency. In 2004 Gastrointestinal Cancers Symposium, abstract 109, 2004.
33. Overman MJ, Koptez S, Morris J, Ajani JA, Hoff PM, Abbruzzese JL, Wolff RA: A retrospective review of platinum-based versus non-platinum based chemotherapy in the treatment of metastatic adenocarcinoma of the small bowel (SBA). In: 2007 Gastrointestinal Cancers Symposium, 2007.
34. Polyzos A, Kouraklis G, Giannopoulos A et al.: Irinotecan as salvage chemotherapy for advanced small bowel adenocarcinoma: A series of three patients. J Chemother 15, 503-506 (2003)
35. Overman MJ, Varadhachary G, Lin E, et al.: Final response data of a phase II study of capecitabine and oxaliplatin (CAPOX) in advanced adenocarcinoma of the small bowel or ampulla of Vater. J Clin Oncol 2008, 26(May 20 suppl).
36. Jigyasu D, Bedikian AY, Stroehlein JR: Chemotherapy for primary adenocarcinoma of the small bowel. Cancer 53, 23-25 (1984)
37. Gibson MK, Holcroft CA, Kvols LK, Haller D: Phase II study of 5-fluorouracil, doxorubicin, and mitomycin C for metastatic small bowel adenocarcinoma. Oncologist 10, 132-137 (2005)
38. Crawley C, Ross P, Norman A, Hill A et al.: The Royal Marsden experience of a small bowel adenocarcinoma treated with protracted venous infusion 5-fluorouracil. Br J Cancer 78, 508-510 (1998)
39. Aparicio T, Moulin V, Locher C, et al.: Efficacy of recent chemotherapy regimen in advanced small bowel carcinoma. J Clin Oncol, In 2007 ASCO Annual Meeting Proceedings Part I, vol. 25, 2007.
40. Copson ER, Darby A, Harvey M et al.: Epirubicin, cisplatin and infusional 5-fluorouracil chemotherapy for locally advanced and metastatic small bowel adenocarcinoma. Proc Am Soc Clin Oncol 21, 2347 (2002)